Heramed Ltd (HMD) - Total Assets

Latest as of June 2025: AU$1.04 Million AUD ≈ $734.01K USD

Based on the latest financial reports, Heramed Ltd (HMD) holds total assets worth AU$1.04 Million AUD (≈ $734.01K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Heramed Ltd book value and equity for net asset value and shareholders' equity analysis.

Heramed Ltd - Total Assets Trend (2016–2024)

This chart illustrates how Heramed Ltd's total assets have evolved over time, based on quarterly financial data.

Heramed Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Heramed Ltd's total assets of AU$1.04 Million consist of 82.8% current assets and 17.2% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$0.00	112.7%
Accounts Receivable	AU$162.18K	5.8%
Inventory	AU$374.83K	13.5%
Property, Plant & Equipment	AU$37.68K	1.4%
Intangible Assets	AU$732.88K	26.4%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2016–2024)

This chart illustrates how Heramed Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Heramed Ltd (HMD) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Heramed Ltd's current assets represent 82.8% of total assets in 2024, an increase from 82.3% in 2016.
Cash Position: Cash and equivalents constituted 112.7% of total assets in 2024, up from 77.9% in 2016.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 16.0% in 2016.
Asset Diversification: The largest asset category is intangible assets at 26.4% of total assets.

Heramed Ltd Competitors by Total Assets

Key competitors of Heramed Ltd based on total assets are shown below.

Company	Country	Total Assets
Vitrolife AB ST:VITR	Sweden	Skr11.12 Billion
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	China	CN¥805.10 Million
Tellgen Corp SHE:300642	China	CN¥2.00 Billion
Lumos Diagnostics Holdings Ltd AU:LDX	Australia	AU$20.81 Million
T&R Biofab Co. Ltd KQ:246710	Korea	₩83.86 Billion
Ok Biotech Co Ltd TW:4155	Taiwan	NT$3.89 Billion
Promimic AB ST:PRO	Sweden	Skr75.71 Million
Memphasys Ltd AU:MEM	Australia	AU$10.45 Million

Heramed Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.04	1.74	5.17
Quick Ratio	2.33	1.48	5.06
Cash Ratio	0.00	0.00	0.00
Working Capital	AU$686.82K	AU$639.15K	AU$2.01 Million

Heramed Ltd - Advanced Valuation Insights

This section examines the relationship between Heramed Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	77.33
Latest Market Cap to Assets Ratio	13.34
Asset Growth Rate (YoY)	37.8%
Total Assets	AU$2.78 Million
Market Capitalization	$37.04 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Heramed Ltd's assets at a significant premium (13.34x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Heramed Ltd's assets grew by 37.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Heramed Ltd (2016–2024)

The table below shows the annual total assets of Heramed Ltd from 2016 to 2024.

Year	Total Assets	Change
2024-12-31	AU$2.78 Million ≈ $1.96 Million	+37.78%
2023-12-31	AU$2.01 Million ≈ $1.43 Million	-51.91%
2022-12-31	AU$4.19 Million ≈ $2.96 Million	-8.44%
2021-12-31	AU$4.57 Million ≈ $3.24 Million	+44.11%
2020-12-31	AU$3.17 Million ≈ $2.25 Million	-11.96%
2019-12-31	AU$3.61 Million ≈ $2.55 Million	-15.60%
2018-12-31	AU$4.27 Million ≈ $3.02 Million	+242.42%
2017-12-31	AU$1.25 Million ≈ $882.84K	-27.77%
2016-12-31	AU$1.73 Million ≈ $1.22 Million	--

About Heramed Ltd

AU:HMD Australia Medical Devices

Market Cap

$37.04 Million

AU$52.34 Million AUD

Market Cap Rank

#22962 Global

#875 in Australia

Share Price

AU$0.05

Change (1 day)

-6.00%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$0.32